Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-29

Clinical Trial Update: A Trial of Antroquinonol in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing Antroquinonol in patients with Atopic Dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antroquinonol (antroquinonol)

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED